Suppr超能文献

通过高通量筛选鉴定出的免疫调节核酸外切酶PLD3和PLD4的调节剂。

Modulators of immunoregulatory exonucleases PLD3 and PLD4 identified by high-throughput screen.

作者信息

Shirey Ryan J, Turner Lewis D, Lairson Luke L, Janda Kim D

机构信息

Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, United States.

Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, United States.

出版信息

Bioorg Med Chem Lett. 2021 Oct 1;49:128293. doi: 10.1016/j.bmcl.2021.128293. Epub 2021 Jul 28.

Abstract

PLD3 and PLD4 have recently been revealed to be endosomal exonucleases that regulate the innate immune response by digesting the ligands of nucleic acid sensors. These enzymes can suppress RNA and DNA innate immune sensors like toll-like receptor 9, and PLD4-deficent mice exhibit inflammatory disease. Targeting these immunoregulatory enzymes presents an opportunity to indirectly regulate innate immune nucleic acid sensors that could yield immunotherapies, adjuvants, and nucleic acid drug stabilizers. To aid in delineating the therapeutic potential of these targets, we have developed a high-throughput fluorescence enzymatic assay to identify modulators of PLD3 and PLD4. Screening of a diversity library (N = 17952) yielded preferential inhibitors of PLD3 and PLD4 in addition to a PLD3 selective activator. The modulation models of these compounds were delineated by kinetic analysis. This work presents an inexpensive and simple method to identify modulators of these immunoregulatory exonucleases.

摘要

最近发现PLD3和PLD4是内体核酸外切酶,可通过消化核酸传感器的配体来调节先天免疫反应。这些酶可以抑制RNA和DNA先天免疫传感器,如Toll样受体9,并且PLD4缺陷小鼠表现出炎症性疾病。靶向这些免疫调节酶为间接调节先天免疫核酸传感器提供了机会,这可能会产生免疫疗法、佐剂和核酸药物稳定剂。为了帮助确定这些靶点的治疗潜力,我们开发了一种高通量荧光酶法来鉴定PLD3和PLD4的调节剂。对一个多样性文库(N = 17952)进行筛选,除了得到一种PLD3选择性激活剂外,还得到了PLD3和PLD4的优先抑制剂。通过动力学分析描绘了这些化合物的调节模型。这项工作提出了一种廉价且简单的方法来鉴定这些免疫调节核酸外切酶的调节剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验